Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003415695 | SCV004107063 | pathogenic | RHAG-related disorder | 2023-01-13 | criteria provided, single submitter | clinical testing | The RHAG c.157+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in the compound heterozygous state in a patient with Rh-deficiency syndrome, with functional studies indicating it disrupted normal splicing (Huang et al 1998. PubMed ID: 9716608). This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-49604368-C-T). Variants that disrupt the consensus splice donor site in RHAG are expected to be pathogenic. This variant is interpreted as pathogenic. |
OMIM | RCV000013936 | SCV000034183 | pathogenic | Rh-null, regulator type | 1998-10-01 | no assertion criteria provided | literature only |